Effect of PPAR-gamma agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes and coronary artery disease

Background: Targeting metabolic determinants of exercise performance with pharmacological agents that would mimic/potentiate the effects of exercise represents an attractive clinical alternative to...